Tuberous Sclerosis Skin Lesions Improved on Everolimus The Oncology Report PRAGUE – Everolimus significantly improved the skin lesions of tuberous sclerosis complex in two phase-III clinical trials, Dr. Sergiusz Jozwiak reported at the annual congress of the European Academy of Dermatology and Venereology. Tuberous sclerosis ... |
